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Abstract
The control of RNA stability is a key determinant in cellular gene expression. The stability of any transcript is modulated
through the activity of cis- or trans-acting regulatory factors as well as cellular quality control systems that ensure the
integrity of a transcript. As a result, invading viral pathogens must be able to subvert cellular RNA decay pathways capable
of destroying viral transcripts. Here we report that the Kaposi’s sarcoma-associated herpesvirus (KSHV) ORF57 protein binds
to a unique KSHV polyadenylated nuclear RNA, called PAN RNA, and protects it from degradation by cellular factors. ORF57
increases PAN RNA levels and its effects are greatest on unstable alleles of PAN RNA. Kinetic analysis of transcription pulse
assays shows that ORF57 protects PAN RNA from a rapid cellular RNA decay process, but ORF57 has little effect on
transcription or PAN RNA localization based on chromatin immunoprecipitation and in situ hybridization experiments,
respectively. Using a UV cross-linking technique, we further demonstrate that ORF57 binds PAN RNA directly in living cells
and we show that binding correlates with function. In addition, we define an ORF57-responsive element (ORE) that is
necessary for ORF57 binding to PAN RNA and sufficient to confer ORF57-response to a heterologous intronless b-globin
mRNA, but not its spliced counterparts. We conclude that ORF57 binds to viral transcripts in the nucleus and protects them
from a cellular RNA decay pathway. We propose that KSHV ORF57 protein functions to enhance the nuclear stability of
intronless viral transcripts by protecting them from a cellular RNA quality control pathway.
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Introduction
Post-transcriptional events in mRNA biogenesis are of central
importance to the fidelity and regulation of gene expression.
Cellular factors regulate nearly every step of RNA metabolism
including transcription elongation, RNA splicing, 39 end forma-
tion, nuclear export, translation, etc. In fact, genome-wide
profiling experiments demonstrate that a significant percent of
the observed changes in RNA levels are dictated by regulation of
the stability of a transcript rather than its transcription (e.g. [1,2]).
RNA half-life can be modulated directly, through the activities of
regulatory stabilizing or destabilizing protein factors or small
RNAs [3–5]. In addition, RNA quality control pathways ensure
aberrant transcripts are less stable than their functional counter-
parts [6]. Given the importance of these pathways for gene
expression, it is no surprise that viruses have evolved mechanisms
to counteract pathways that otherwise would lead to the
destruction of viral transcripts [3,7].
The Kaposi’s sarcoma-associated herpesvirus (KSHV) is a
member of the gammaherpesvirus family that causes Kaposi’s
sarcoma, a common AIDS-associated malignancy, as well as the
lymphoproliferative disorders primary effusion lymphoma (PEL)
and some cases of multicentric Castleman’s disease (MCD) [8–10].
The life cycle of KSHV includes a latent phase in which the viral
DNA is maintained in infected host cells as a circular episome.
During latency, few viral genes are expressed and no viral
replication occurs. When the KSHV lytic phase is reactivated, a
well-regulated cascade of gene expression is initiated by the viral
transactivator ORF50 (Rta) resulting in infectious virus production
[11–13]. Like all herpesviruses, the KSHV genome is nuclear and
its genes are expressed utilizing the host cell transcription, RNA
processing, and translation machinery. In many respects, KSHV
genes resemble those of their host; that is, they have canonical
promoter elements, 39-end formation signals, and consensus pre-
mRNA splice sites.
However, KSHV genes differ from canonical cellular genes in
several relevant ways. Some transcripts are bicistronic, KSHV
introns are smaller than the average size of a mammalian intron,
and genes are more closely arranged in the genome than host
genes. Most importantly for the present work, ,70% of KSHV
genes lack introns [14], whereas most human protein-coding genes
contain multiple introns [15]. This difference in gene structure has
implications for the expression of viral genes. The presence of an
intron in a pre-mRNA and/or the changes in ribonucleoprotein
particle (RNP) composition that result from splicing promote the
efficiency of almost every stage of gene expression, including
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export, RNA localization, and translation [16–27]. As a result,
transgenes containing an intron are often expressed at significantly
higher levels than those same genes lacking an intron [18]. To
compensate for the lack of introns or splicing, viruses that express
unspliced or intronless transcripts have evolved mechanisms that
promote efficient gene expression in the absence of splicing
[28–33].
KSHV encodes a viral post-transcriptional regulator of gene
expression called ORF57 (Mta, KS-SM) that is essential for viral
replication [34,35]. ORF57 is a member of a conserved family of
herpesvirus proteins that post-transcriptionally enhance gene
expression [29–33]. ORF57 has been implicated in a variety of
steps of RNA biogenesis from transcription to translation and it
increases the efficiency of intronless gene expression [30,31,36,37].
ORF57 has been reported to interact with ORF50 and to enhance
transcription in a promoter and cell-type specific manner [37–39].
In addition, ORF57 binds cellular export factors and promotes the
nuclear export of at least a subset of intronless viral mRNAs
[40–43]. Unlike the herpes simplex homolog (HSV) ICP27, which
contributes to host gene shut-off by inhibiting splicing, ORF57
promotes the splicing of some viral mRNAs [35,44], and splicing
activity is also seen with the Epstein-Barr virus (EBV) ORF57
homolog, SM [45]. ORF57 has further been suggested to play a
role in translation of an internal ribosome entry site-containing
reporter [46]. Thus, ORF57 is a multifunctional regulator of
mRNA biogenesis that may, in part, compensate for the lack of
introns in viral gene expression.
ORF57 is critical for the accumulation of the polyadenylated
nuclear (PAN) RNA (nut1, T1.1) [34,35,37,42], a non-coding
nuclear transcript that accumulates to high levels during the lytic
phase of viral infection [47,48]. The PAN RNA promoter is
ORF50-dependent [49,50], and PAN RNA accumulation further
depends on the activity of a 79-nucleotide (nt) RNA element,
called the ENE [51–53]. Mechanistically, the ENE interacts in cis
with the poly(A) tail of PAN RNA resulting in the sequestration of
the poly(A) tail from exonucleases. Detailed kinetic analysis of the
effects of the ENE on PAN RNA decay in transfected cells showed
that PAN RNA is subject to two kinetically distinguishable decay
pathways, one with a very short half-life (10–20 min) and another
with a longer half-life (3–5 hrs). ENE-lacking or ENE-mutant PAN
transcripts are more likely to be degraded in the rapid RNA decay
pathway than are their wild-type ENE containing counterparts.
Because the ENE is sufficient to increase the nuclear accumulation
of heterologous intronless transcripts, we further proposed that this
rapid decay pathway is part of a nuclear RNA surveillance system
that rapidly degrades inefficiently exported mRNAs.
ORF57-mediated enhancement of the exclusively nuclear PAN
RNA suggests that it may be involved in inhibiting the proposed
RNA surveillance mechanism. Here, we test this idea and find that
ORF57 stabilizes PAN RNA, particularly those transcripts that
lack the ENE. We see no ORF57-dependent effect on RNA
polymerase II (pol II) density on the PAN RNA gene nor does
ORF57 lead to PAN RNA export. Therefore, we conclude that
the observed stability enhancement constitutes the major effect of
ORF57 on PAN RNA accumulation. In addition, ORF57 binds
PAN RNA directly in vivo and a deletion of the 59 portion of PAN
RNA, dubbed the ORF57-responsive element (ORE), reduces
ORF57 binding and ORF57 response. We show that tethering of
ORF57 to an ORE-deleted PAN RNA restores ORF57-mediated
up-regulation. Finally, we show that the ORE is sufficient to confer
increased ORF57-response to a heterologous intronless b-globin
mRNA, but not its spliced counterpart. We conclude that ORF57
protects viral transcripts from the same cellular RNA decay
pathway that the ENE protects from in cis and that its stabilization
activity is dependent on ORF57 binding to target RNAs.
Results
ORF57 protects transcripts from rapid decay
If ORF57 protects transcripts from RNA decay pathways in
vivo, we reasoned that the effects of ORF57 would be more
pronounced on unstable ENE-lacking transcripts than on their
ENE-containing counterparts. To test this idea, we compared the
RNA levels of PAN RNA containing the ENE (PAN-WT) to PAN
RNA lacking the ENE (PAN-D79) in the absence of ORF57 or in
its presence. We transfected HEK293 cells with constructs that
express PAN-WT or PAN-D79 and co-transfected ORF57-
expression constructs at two concentrations or empty vector. After
,18-24 hours, we extracted total RNA, and quantified relative
RNA levels by northern blot (Figure 1). Consistent with published
results [34,35,37,42], ORF57 increases wild-type PAN RNA levels
in a dose-dependent fashion (Figure 1A, lanes 1–3). Quantitation
of these data show that, at the highest ORF57 concentration
tested, PAN RNA is ,3.4-fold more abundant (Figure 1B). As
predicted from our model, ENE-lacking transcripts show an even
greater response to ORF57, ,11-fold (lanes 4–6 and Figure 1B).
Because the ENE is involved in RNA stability, these results are
consistent with the conclusion that ORF57 increases the half-life of
PAN RNA.
To directly examine the effects of ORF57 on PAN RNA half-
life, we employed a transcription pulse strategy [54]. In these
experiments, we transfected HEK293 Tet-off advanced (293TOA)
cells with TRP-D79, a plasmid that expresses the ENE-lacking
PAN-D79 transcript from a tetracycline-responsive promoter [52].
In 293TOA cells, transcription from this promoter is turned off in
the presence of doxycycline (dox, a tetracycline analog), and is
induced in its absence. In our initial experiments, we examined the
effects of ORF57 on PAN RNA decay after a two-hour
transcription pulse (Figure 2). As expected, TRP-D79 RNA was
undetectable prior to transcription pulse, but can be detected after
Author Summary
In order to replicate efficiently, a virus must ensure that its
genes are properly expressed in the context of an infected
host cell. Recent work has demonstrated that eukaryotic
cells have RNA quality control pathways that degrade
improperly processed, aberrant RNAs. Our published
findings using an unusual Kaposi’s sarcoma-associated
herpesvirus (KSHV) nuclear RNA, called PAN RNA, have
suggested that intronless polyadenylated transcripts are
subject to such a quality control system. Because most
KSHV genes lack introns, we hypothesized that KSHV must
have evolved mechanisms that bypass this quality control
system. In support of this idea, we show that the ORF57
protein, a multifunctional enhancer of KSHV gene expres-
sion, binds to and stabilizes PAN RNA. We further define an
element called the ORF57-responsive element (ORE) in
PAN RNA that is necessary for ORF57-binding and activity
on PAN RNA. In addition, we show that the ORE is
sufficient to confer ORF57-responsiveness to a heterolo-
gous intronless mRNA, but not its spliced counterpart.
These observations substantiate the model that ORF57
enhances KSHV gene expression by protecting viral
transcripts from host RNA surveillance pathways. More
broadly, these data suggest that viruses producing
intronless nuclear RNAs require mechanisms to evade
host quality control mechanisms.
KSHV ORF57 Binds and Stabilizes PAN RNA
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of the decay profiles clearly shows an increase in RNA stability
when ORF57 is expressed (Figure 2B, top). Interestingly, the
mobility of a portion of remaining transcripts after transcription
shut-off is reduced while others show increased mobility. We have
determined that these mobility changes are due to differences in
poly(A) tail length (data not shown). The relationship between
changes in poly(A) length and ORF57 function is currently under
investigation and will be described elsewhere (see Discussion). We
also examined the effects of ORF57 on TRP-WT, a PAN
expression construct containing the ENE [52]. However, in
293TOA cells this plasmid produced an extremely stable
transcript (t1/2.24hr), impractical for use in decay assays. Overall,
these data demonstrate that ORF57 increases the half-life of
unstable PAN RNA transcripts.
Previous studies showed that PAN RNA is subject to two decay
pathways with different kinetic properties [51,52]. That is, one
pool of PAN RNA transcripts is degraded very rapidly with half-
lives of ,10-20 minutes, while another pool of transcripts is
degraded more slowly (t1/2 ,3-5hrs). The presence of the ENE
appears to protect transcripts from the rapid decay system
resulting in a decrease in the fraction of transcripts that are
observed in this population. Consistent with these published
findings, the decay profiles in Figure 2B are nicely fit by two-
component exponential decay curves where the two components
represent the two pools of transcripts. Using regression analysis, we
can determine the decay parameters in PAN RNA degradation,
including the fraction of transcripts undergoing rapid decay and
the half-life of each population. Because ENE-lacking transcripts
are preferentially up-regulated by ORF57, we predicted that, like
the ENE, ORF57 expression would decrease the fraction of PAN
transcripts in the rapid RNA decay pathway.
To test this idea, we performed regression analysis of the data
for TRP-D79 RNA decay in the presence or absence of ORF57
(Figure 2B, Table S1 and Figure S1). Examination of the kinetic
parameters shows that in the absence of ORF57, 73% of the
transcripts are in the rapidly degrading population (t1/2 ,7.8 min)
(Figure 2C). In contrast, only 51% of the transcripts are degraded
rapidly when ORF57 is co-expressed, a statistically significant
decrease. Because the more slowly degrading transcripts accumu-
late over time, the fraction of transcripts observed in the rapidly
degrading pool decreases when longer transcription pulse times
are employed [51]. If ORF57 decreases the fraction of transcripts
that degrade rapidly, it follows that the observed rapidly degrading
fraction would decrease more quickly when ORF57 is present.
Indeed, the effects of ORF57 on TRP-D79 RNA decay are even
more apparent after an 18-hour transcription pulse (Figure 2A and
Figure 2B). In this case, the apparent half-life (i.e. the time
difference at 50% remaining, Figure 2B) is increased ,8-fold.
More importantly, the percent of transcripts degrading rapidly in
the presence of ORF57 is reduced to 15%, while 57% is rapidly
degraded in its absence (Figure 2C). Taken together, these data
strongly argue that ORF57 enhances PAN RNA levels by
protecting it from a rapid cellular RNA decay pathway.
ORF57 up-regulation of PAN RNA occurs after
transcription initiation
Previous reports suggested that ORF57 enhances transcription
rates of specific promoters in certain cell types, including the PAN
RNA promoter in 293 cells [37–39]. Even though we see an
increase in PAN RNA half-life in the presence of ORF57, it
remains possible that a significant portion of the up-regulation of
PAN RNA by ORF57 is at the level of RNA synthesis rather than
decay. To test the effects of ORF57 on transcription initiation, we
initially examined the response of PAN RNA to ORF57 from
three different promoters (Figure 3A). Consistent with the results
of others, PAN RNA expression from the cytomegalovirus
immediate early (CMVIE) promoter is responsive to ORF57
[36,37,39]. We extended this analysis by examining PAN RNA
steady-state levels driven by the cellular elongation factor 1a
(EF1a) and viral SV40 promoters (Figure 3A). Each of these
constructs is 39 processed using the PAN RNA cleavage and
polyadenylation signals. For every promoter tested, ORF57
increased PAN RNA levels in a dose-dependent fashion
supporting a post-transcriptional role for ORF57. Interestingly,
the magnitude of the change differs among the constructs and this
does not necessarily correlate with the strength of each promoter.
Figure 1. ORF57 preferentially enhances the levels of an
unstable nuclear RNA. (A) Top, schematic diagram of the constructs
used. Both are driven by the PAN promoter (gray) and have the PAN 39-
end formation signals (black). PAN-D79 has the 79-nt ENE sequence
deleted. Bottom, representative northern blot showing a dose-
dependent response of PAN-WT and PAN-D79 to ORF57. Cells were
co-transfected with PAN and ORF57 expression plasmids as indicated.
Because these constructs use the ORF50-dependent PAN promoter, an
ORF50 expression plasmid was also co-transfected. Control panels show
signal from a co-transfected plasmid that controls for transfection and
loading efficiencies. (B) Quantitation of dose-dependent experiments
shown in (A). Values are normalized to the no ORF57 control lanes; error
bars show standard deviation (n=4).
doi:10.1371/journal.ppat.1000799.g001
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promoters are the strongest and weakest promoters, respectively
(Figure S2). However, PAN-WT RNA driven by each of these
promoters is increased by similar margins at the highest ORF57
expression levels (3.5-fold and 2.8-fold) (Figure 1B and Figure 3A).
In contrast, the CMVIE and EF1a promoters both show greater
increases in steady-state levels in response to ORF57 (9.5 and 6.7-
fold, respectively). These data suggest that the effect of ORF57 on
PAN RNA is not due to any promoter-specific element, but that
magnitude of the ORF57 enhancement may be linked to a
qualitative difference in these promoters.
To further test the effects of ORF57 on PAN RNA
transcription, we examined the pol II density on the PAN RNA
gene by chromatin immunoprecipitation assays (ChIP). In these
experiments, ChIP was performed using antibodies to RNA
polymerase II and the relative levels of co-immunoprecipitating
DNA were compared. We examined DNA from the 59 and 39 ends
of PAN RNA (Figure 3B) to assess polymerase density across the
PAN gene. First, we determined the relative polymerase density on
TRP-D79 in the presence and absence of ORF57 (Figure 3B) and
saw only a slight increase in polymerase density on either the 59 or
39 portion of the PAN gene when ORF57 was co-expressed (,1.3-
fold). As expected, in the presence of dox, the polymerase density
significantly decreases. Second, we assayed polymerase density on
the PAN RNA gene when transcription is driven from the PAN
promoter (Figure 3C). Because this promoter depends on the
ORF50 viral transactivator, we included samples lacking ORF50
as negative controls. Comparing samples containing or lacking
Figure 2. ORF57 protects transcripts from rapid RNA decay. (A) Top, schematic diagram of TRP-D79 construct, which contains the Tet-
responsive promoter driving PAN-D79. Bottom, representative northern blots showing typical transcription pulse data. The upper panels show data
from a two-hour pulse in the presence or absence of ORF57 as indicated. The ‘‘-2’’ lanes are samples taken prior to the pulse. The lower panels show
the results from an 18-hr transcription pulse. The asterisks mark the mobility of hyperadenylated transcripts. Cellular 7SK serves as a loading control.
(B) Regression analysis of the transcription pulse data. Curves are two-component exponential decay curves as previously described [51]; error bars
are standard deviation (n=3). (C) The percent of transcripts undergoing rapid decay was derived using regression analyses. Other kinetic parameters
are given in Table S1 and Figure S1.
doi:10.1371/journal.ppat.1000799.g002
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59 end of the PAN gene. Similarly, we saw minimal ORF57-
dependent difference in signal from the 39 end of PAN gene,
although there is lower signal in this sample (data not shown).
Taken together, these data strongly support the conclusion that the
predominant effect of ORF57 on PAN RNA steady-state levels
occurs subsequent to transcription initiation.
ORF57 does not induce the cytoplasmic accumulation of
PAN RNA
ORF57, like its homologs in other herpesviruses, has been
implicated in the nuclear export of intron-lacking viral mRNAs
[29,32,40–42,55]. Because the machinery involved in RNA decay
differs between the cytoplasm and the nucleus, it stands to reason
that a change in subcellular localization would affect RNA decay
profiles. Therefore, we performed in situ hybridization to verify
that PAN RNA remains nuclear in the presence of ORF57. As
shown in Figure 4, PAN-D79 RNA localizes to faint spots in the
nucleus (top panels), with a few cells demonstrating a more diffuse
pattern (data not shown and Figure S3). In the presence of
ORF57, PAN-D79 RNA is also observed strictly in the nucleus
(Figure 4, middle panels). The signal intensity, the number of cells
showing signal above background, and the percentage of cells with
diffuse nuclear staining were all increased in the presence of
ORF57 and account for the higher levels of PAN-D79 in the
presence of ORF57 (data not shown). Importantly, no cytoplasmic
PAN RNA signal was detected. In addition, TRP-D79 RNA was
observed exclusively in the nucleus (Figure S3), as was wild-type
PAN RNA driven from either the PAN or TRP promoters (data
not shown). As an additional control, since many in situ
hybridization protocols will ‘‘wash away’’ cytoplasmic RNA, we
tested whether we could detect cytoplasmic signal by examining
the localization of a spliced b-globin reporter mRNA. In this case,
cytoplasmic signal was observed (Figure 4, bottom panels). These
results demonstrate that the increase in PAN RNA stability in the
presence of ORF57 is not the result of PAN RNA export to the
cytoplasm. Because ORF57 enhances RNA stability, but has little
or no effect on PAN RNA export or transcription, we conclude
that the effect of ORF57 on PAN RNA accumulation is the result
of increased nuclear RNA stability.
ORF57 binds PAN RNA directly in living cells
ORF57 could stabilize PAN RNA by one of two non-mutually
exclusive mechanisms. First, ORF57 may inhibit the activity of
RNA decay enzymes, either by binding and inactivating them
directly or by decreasing their expression. Second, ORF57 may
interact with transcripts and protect the bound RNAs, directly or
indirectly, from decay enzymes. The second model predicts that
ORF57 is in a complex with PAN RNA and that this binding is
necessary for protection by ORF57. Even though a previous
report suggested that ORF57 did not bind to PAN RNA in vitro
[56], we investigated whether ORF57 bound to PAN RNA in
vivo.
One difficulty in examining RNA-protein interactions using co-
immunoprecipitation techniques is that RNA-protein complexes
frequently reassort in cellular extract [57,58]. That is, an RNA-
binding protein will associate with specific transcripts in an extract
that were not bound in vivo. Therefore, in order to conclude that
an RNA-protein interaction occurs in cells, it is imperative to test
whether a given RNA-protein complex forms subsequent to lysis.
To do this, we employed a ‘‘cell-mixing’’ experiment [57,58]
(Figure 5A). We induced lytic reactivation of KSHV in HH-B2
cells, a latently infected PEL cell line, with sodium butyrate (NaB)
to initiate the expression of lytic genes including PAN RNA. After
Figure 3. PAN RNA is posttranscriptionally up-regulated by
ORF57. (A) Northern blots showing a dose-dependent response of PAN
RNA driven by the CMVIE, EF1a, and SV40 promoters. Relative values
and standard deviations are shown below; p values are given for a
comparison of the 0 and 0.4 mg ORF57 quantities (CMVIE, n=3; EF1a
and SV40, n=5). (B) Pol II ChIP results using TRP-D79. ChIP assays were
done in the presence of dox or in its absence in cells transfected with or
without ORF57 as indicated. PCR amplicons were nt 93-147 (59) and
777-863 (39) relative to the transcription start site. The diagram shown
below is not to scale. Quantitation and background correction are
described in the Materials and Methods section (PAN 59: +dox, n=4,
+/2ORF57, n=5; PAN 39: +dox n=2, +/2 ORF57 n=3). P-values are
shown for the +/2ORF57 data sets. (C) Pol II ChIP results with PAN-D79;
details are the same as (B). (PAN 59: n=4; PAN 39: n=2). The increased
signal for the 39 samples in the –ORF50 control is a result of lower signal
for the 39 amplicon in the +ORF50 samples and is not due to an increase
in the amount of background signal (data not shown).
doi:10.1371/journal.ppat.1000799.g003
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cells transfected with Flag-tagged ORF57 (Fl-ORF57) or with
untagged ORF57 expression constructs. After combining intact
cells, the cells were lysed and subjected to immunoprecipitation
(IP) with anti-Flag antibodies. PAN RNA, which is exclusively
derived from the HH-B2 cells, was efficiently and specifically
immunoprecipitated with the anti-Flag beads (Figure 5B). Because
PAN RNA is not produced in the same cells as the Fl-ORF57, this
result clearly indicates that ORF57 interacts with RNAs in cell
lysate and that RNAs that co-immunoprecipitate with ORF57 do
not necessarily reflect RNP composition in vivo. As a result,
caution must be taken in the interpretation and experimental
design of RNA immunoprecipitation experiments with ORF57.
To control for ORF57-RNA reassortment in cell extract, we
employed an ultraviolet light (UV) cross-linking protocol [57]. We
transfected HEK293 cells with PAN-WT and Fl-ORF57 or
untagged ORF57 expression plasmids and exposed the cells to UV
light to covalently cross-link protein to RNA. Cells were lysed
under stringent conditions and ORF57 was immunoprecipitated
with anti-Flag antibodies. Subsequently, we detected PAN RNA
signal by northern blot and quantitated this signal as a percent of
input RNA (Figure 5C and 5D). Using this procedure, PAN RNA
is immunoprecipitated from extracts containing Fl-ORF57, but
not the untagged control (compare lanes 5 and 6, top panel). Most
importantly, because living cells were exposed to UV, a UV-
dependent interaction reflects an interaction in cells. Because the
‘‘no UV’’ control shows little detectable signal (lane 4), we
conclude that ORF57 associates with PAN RNA in cells.
Moreover, UV cross-linking is limited to interactions in which
the RNA and protein are in close contact, so we can further
conclude that ORF57 binds directly to PAN RNA in vivo.
Little is known about the requirements for ORF57 recruitment
or RNA-binding in vivo, so we tested whether cis-acting elements
in PAN RNA are necessary for the ORF57-PAN RNA
interactions. We utilized a series of four previously described
PAN RNA expression constructs with 300-nt overlapping
deletions in PAN RNA, called PAND1-D4 [53]. ORF57 cross-
linked to PAND2, PAND3, and PAND4 with similar efficiency as
PAN-WT (Figures 5C and 5D). In contrast, cross-linking to
PAND1 RNA was only slightly higher than background signal. We
previously reported that PAND1 RNA is expressed at lower levels
than PAN-WT RNA [53] (see below). To verify that the lower
expression of PAND1 was not responsible for its lack of ORF57
binding, we performed experiments in which we transfected less of
the PAN-WT expression plasmid, to render its steady-state levels
similar levels to PAND1 (data not shown). In this case, efficient
binding to PAN-WT was maintained, so we conclude that reduced
ORF57-PAND1 cross-linking is not due to lower PAND1
expression levels. These results demonstrate that sequences near
the 59 end of PAN RNA are necessary for efficient cross-linking of
ORF57 to PAN RNA in cultured cells.
ORF57 binding correlates with ORF57 activity
The model that ORF57-RNA interactions are required for
activity predicts that diminished binding of ORF57 to PAND1 will
result in decreased ORF57 activity. Therefore, we examined the
accumulation of PAND1 in the presence of increasing amounts of
ORF57 (Figure 6A). Under the same conditions in which ORF57
Figure 4. PAN-D79 RNA remains nuclear in the presence of ORF57. Top, in situ hybridization to PAN-D79 in transiently transfected HEK293
cells (middle panels) shows that PAN RNA remains nuclear in the presence or absence (vector) of ORF57 as indicated. Nuclei are stained with DAPI
(left) and merged images are shown (right). Bottom, cytoplasmic signal from a co-transfected b-globin reporter construct (bD1; Figure 8) serves as a
control for maintenance of cytoplasmic RNA. The bD1 localization was unaffected by ORF57 (data not shown).
doi:10.1371/journal.ppat.1000799.g004
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we observe no statistically significant change in PAND1 levels in
the presence of ORF57. Thus, the loss of ORF57 binding to
PAND1 correlates with loss of PAN RNA up-regulation. Taken
with data presented below, our results show that the 59 end of
PAN RNA (nt 1–312) contains an ORF57-responsive element
(ORE).
The loss of binding of ORF57 to PAND1 could be due to any
one of several non-mutually exclusive models. For example, the
ORE may contain a high-affinity binding site for ORF57.
Alternatively, there may be a cis-acting sequence in the ORE
whose activity is necessary for ORF57 function. As a result, loss of
this cis-acting sequence disrupts the ORF57 up-regulatory
pathway. Consistent with this idea, previously published data
suggested that nt 13–312 contain an activity important for PAN
RNA accumulation [53]. Therefore, we examined whether
ORF57-responsiveness correlates with the RNA accumulation
activity provided by this region of PAN RNA. Using northern
blots (data not shown), we confirmed that PAND1 is expressed at
,5-fold lower levels than PAN-WT when ORF57 is not co-
expressed (Figure 6B). In contrast, when PAND1 is placed behind
a CMVIE promoter (CMV-D1), the expression levels are reduced
only slightly, ,30% (Figure 6B). Thus, this cis-acting PAN RNA
accumulation activity found in nt 13–312 is not operative when a
CMVIE promoter is used to express PAN RNA. Using the
CMVIE-driven PAND1 constructs, we next tested the hypothesis
that this activity is related to ORF57-responsiveness. Quantitation
of northern blot data show that CMVIE-driven PAND1 remains
significantly less responsive to ORF57 than CMVIE-driven wild-
type PAN RNA (Figure 6C). CMVIE-driven WT PAN was up-
regulated nearly 10-fold in the presence of ORF57, while the
CMVIE-driven PAND1 RNA levels increase by a factor of only
Figure 5. ORF57 binds PAN RNA in transfected cells. (A) Cell mixing experiment; details described in the text. (B) Northern blot of input (5%),
supernatant (5%), and pellet (100%) RNA from a cell-mixing experiment. The control is an exogenously added transcript that controls for RNA
recovery after immunoprecipitation. (C) Northern blots for PAN RNA showing 5% of the input RNA and 100% of the pellets from a UV cross-linking
experiment. The lanes marked Fl-ORF57 ‘‘–’’were transfected with an ORF57 expression plasmid lacking a Flag-tag. The nucleotides deleted in each of
the PAN RNA variants are listed in parentheses to the left of each panel. One representative control is shown; the control is the same as in (B). (D)
Quantitation of the results from UV cross-linking experiments. Average % immunoprecipitation is shown with error bars indicating standard deviation
(PAN-WT, n=4; PAND1, PAND3, PAND4, n=3; PAND2, n=2). The p-values compare the percent immunoprecipitation of the +UV/+Fl-ORF57 to that of
PAN-WT.
doi:10.1371/journal.ppat.1000799.g005
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responsiveness of PAND1 is unrelated to its reduced levels from
the PAN promoter. Moreover, these data show that the ORE
functions in a promoter-independent fashion.
ORF57 binding is sufficient to restore up-regulation to
PAND1
Loss of ORF57 binding to PAN RNA correlates with loss of
function, supporting the model that RNA-binding is necessary for
ORF57 responsiveness. We next tested whether restoration of
ORF57-binding was sufficient to restore ORF57-responsiveness to
PAND1. To do this, we employed a tethering system using the
bacteriophage MS2 coat protein, which binds with high affinity to
a well-defined bacteriophage RNA hairpin sequence [59,60]
(Figure 7). We expressed an amino-terminal fusion of the
bacteriophage MS2 coat protein with ORF57 (NMS2-NLS-Fl-
ORF57) and verified that the fusion did not abrogate ORF57
activity on CMV-driven full-length PAN RNA (lanes 1–8).
Expression of this construct increases PAN RNA accumulation
similarly to Fl-ORF57, (compare lanes 4 and 5 with 2 and 3), while
expression of the MS2-NLS-Fl protein alone did not increase PAN
RNA levels (lanes 6 and 7). Therefore, we conclude that NMS2-
NLS-Fl-ORF57 maintains ORF57 activity. Next, we co-expressed
NMS2-NLS-Fl-ORF57 fusion protein with a CMV-D1 derivative
that includes six binding sites for the MS2 coat protein (Figure 7,
lanes 12,13). In this case, PAN RNA levels increase ,7-fold.
Expression of neither Fl-ORF57 nor MS2-NLS-Fl alone had a
similar effect (lanes 10–11 and 14–15, respectively). Importantly,
the increase depends on the presence of MS2-binding sites in the
RNA: CMV-D1 shows minimal response to MS2-NLS-Fl-ORF57
expression (lanes 20, 21). Thus, tethering of ORF57 to PAND1
transcripts can complement the lack of ORF57-responsiveness of
PAND1. We conclude that the stabilization of PAN RNA by
ORF57 depends on direct interactions between ORF57 and its
target RNA.
The ORE confers ORF57 responsiveness to an intronless
mRNA reporter, but not its spliced counterpart
The data presented above show that the ORE is necessary for
ORF57 responsiveness in the context of PAN RNA. We next
tested whether the ORE is sufficient to confer increased ORF57
response to a heterologous transcript. For these experiments, we
used a series of previously described b-globin reporter constructs
[53]. While wild-type b-globin contains two introns (Figure 8A, b-
wt), these reporters delete either the first (bD1) or both (bD1,2) b-
globin introns. Into the 39 UTR of the bD1,2 construct, we cloned
,300 nt PAN RNA sequences (Figure 8A, right). The sequences,
named PF1-PF4 (PAN fragment 1–4), correspond to the sequences
deleted in PAND1-PAND4 (Figure 5C), respectively, except PF1
extends to the 59-most nucleotide (nt 1-312) and PF4 extends to
the nucleotide immediately preceding the polyadenylation hexa-
mer (nt 703–1052). We co-transfected these constructs with the Fl-
ORF57 expression plasmid and monitored b-globin mRNA levels
by northern blot (Figure 8B, lanes 1–15). Two different schemes
were used to normalize the data (Figure 8C). First, to show the
response of each mRNA variant to Fl-ORF57, we normalized the
b-globin mRNA signal in the presence of Fl-ORF57 to the signal
from the same construct in its absence (Figure 8C, top). Second,
we normalized all the data to the bD1,2 plus 0.4 mg ORF57 (lane
3) to yield information about the expression levels of the reporter
mRNAs relative each other (Figure 8C, bottom).
Our data conclusively demonstrate that the ORE increases the
response of intronless b-globin mRNA to ORF57. In the absence
Figure 6. PAND1 is unresponsive to ORF57. (A) Top, diagram of
PAND1 construct. Below, northern blots showing the lack of a dose-
dependent response of PAND1 RNA to ORF57. Relative values and
standard deviations are shown below (n=8). (B) Comparison of the
expression levels of PAND1 relative to PAN-WT driven from either the
PAN promoter (left, n=3) or the CMVIE promoter (right, n=4). (C)
Quantitation of the relative ORF57-responsiveness of CMV-WT and
CMV-D1, which are diagrammed below (n=3). Data displayed in both
(B) and (C) are from quantitative northern blot experiments.
doi:10.1371/journal.ppat.1000799.g006
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intronless b-globin mRNA in a dose-dependent fashion reaching
,4-fold at the highest ORF57 levels tested (Figure 8B lane 3,
Figure 8C). When PF1, which contains the ORE, is placed in the
b-globin 39 UTR, ORF57 has an even greater effect: bD1,2-PF1
transcripts are up-regulated ,23-fold. This effect is specific to PF1
because PF2, PF3, PF4 do not increase ORF57 response. As
previously shown [51,53], the ENE-containing insert (PF4, lanes
13–15) increases the levels of intronless b-globin mRNA.
However, as in the case of PAN RNA, ORF57-responsiveness
decreases (,2-fold) when the ENE is included in the transcript
(Figure 1). These data show that the ORE is sufficient to confer
increased response to ORF57 in a heterologous context. Because
the ORE was inserted into the b-globin 39 UTR, we can further
conclude that ORE activity is not strictly dependent upon being at
the 59 end of the transcript.
Published data suggest that intronless mRNAs are subject
to degradation by a cellular RNA quality control system
[51–53,61,62] and the data presented above support the model
that ORF57 protects transcripts from this RNA decay pathway.
If this is the case, we reason that ORF57 should have a limited
effect on spliced mRNA abundance, even if the mRNAs contain
the ORE, because spliced transcripts are not subject to the
cellular RNA quality control pathway. To test this idea, we
examined the effects of ORF57 on spliced b-globin mRNA
levels containing (bD1-PF1) or lacking (bD1) the ORE
(Figure 8A). Quantitation of b-globin mRNA accumulation by
northern blot showed that neither of these mRNAs was
significantly altered by ORF57 (Figure 8B, lanes 16–21, and
Figure 8C). Examination of the RNA levels shows that the
spliced mRNAs accumulate to higher levels than the mRNAs
generated from intronless genes, as expected (Figure 8C,
bottom). Interestingly, the levels of the ORE-containing
intronless transcripts approach those of the spliced mRNAs
under the highest levels of ORF57. These results are consistent
with the model that ORF57 protects viral mRNAs from cellular
RNA decay factors that preferentially degrade transcripts
generated from intronless genes.
Discussion
In this report we uncover three novel findings about the ORF57
protein, an essential KSHV protein involved in viral gene
expression. First, these data establish a role for ORF57 in
stabilizing nuclear transcripts. Second, our data show that ORF57
binds directly to its target, PAN RNA, in living cells and that
binding correlates with function. Third, ORF57 and its homologs
can increase the expression of a variety of mRNAs [30–33],
suggesting a relatively nonspecific effect. However, here we
demonstrate the existence of an ORF57-responsive element in
Figure 7. Tethering of ORF57 to CMV-D1 restores ORF57-responsiveness. Top, northern blots showing levels of the PAN RNA and a control
signal from a representative experiment. Fl-ORF57, MS2-NLS-Fl-ORF57, and MS2-NLS-Fl were co-transfected as indicated. The NLS was included to
ensure that the MS2 control was appropriately localized to the nucleus. Because the MS2-NLS-Fl-ORF57 expresses at lower levels than Fl-ORF57 (data
not shown), the transfection conditions were altered from previous experiments (see Materials and Methods). Average values from three experiments
with standard deviations are shown below. The black bars (lanes 1–8), light gray bars (lanes 9–16), and the dark gray bars (lanes 17–24) show relative
RNA levels expressed from the CMV-WT, the CMV-D1-XMS2, and the CMV-D1 plasmid, respectively. These constructs are drawn below (not to scale).
In each experiment, the results were normalized to the average value of the ‘‘no ORF57’’ control, which was performed in duplicate (lanes 1,8; 9,16;
and 17, 24).
doi:10.1371/journal.ppat.1000799.g007
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acting sequences have evolved to recruit ORF57 to its targets.
Consistent with previous reports, our data further show that
ORF57 primarily enhances transcript accumulation from intron-
lacking genes but not from intron-containing genes, even when the
ORE is included in the spliced transcript. Together, these data are
consistent with a model in which ORF57 binds to intronless viral
transcripts and protects them from a cellular RNA quality control
pathway.
The data presented here demonstrate ORF57 stabilizes nuclear
RNAs that would otherwise be rapidly degraded. Using steady-
state analysis (Figure 1) and a transcription pulse assay (Figure 2),
we show that ORF57 increases the stability of an unstable
polyadenylated nuclear RNA. Kinetic analysis further supports the
conclusion that ORF57 is protecting RNAs, at least in part, from
the same rapid RNA decay pathway that the ENE protects
transcripts from in cis [51,52]. Even though ORF57 has been
implicated in mRNA export [40–42], its expression does not lead
Figure 8. The ORE is sufficient to confer ORF57 responsiveness to an intronless mRNA. (A) Left, schematic diagrams of the b-globin
reporter constructs described in the text. Each of these constructs is expressed from a CMVIE promoter and has a bovine growth hormone (BGH)
polyadenylation signal. The b-globin exonic sequence is shown in white boxes, with horizontal lines representing introns. PF* refers to PF1, PF2, PF3,
or PF4. Right, schematic representation of the PAN RNA fragments inserted into the b-globin reporters. The nt position is based on the PAN RNA
transcription start site. (B) Representative northern blot using total RNA from cells in which b-globin constructs were co-transfected with ORF57 as
indicated. These data are all from the same gel and lanes 1–15 are the same exposure; a shorter exposure is shown in lanes 16–21 due to the stronger
signal from the spliced mRNAs. The lower panels show a co-transfected control signal. (C) Quantitation of the northern blot data. In the top graph,
northern blot data were normalized to the ‘‘no ORF57’’ sample for each set. In the bottom graph, the data were normalized to the bD1,2 plus 0.4 mg
ORF57 (lane 3) for each experiment. Thus, the top graph shows the ORF57-responsiveness of each transcript, while the bottom graph yields
information about the mRNA levels generated from each construct.
doi:10.1371/journal.ppat.1000799.g008
KSHV ORF57 Binds and Stabilizes PAN RNA
PLoS Pathogens | www.plospathogens.org 10 March 2010 | Volume 6 | Issue 3 | e1000799to cytoplasmic accumulation of PAN RNA. Thus, we conclude
that the effect of ORF57 on RNA stability is independent of its
proposed function in RNA export. This conclusion is consistent
with previous reports implying that ORF57 stabilizes its target
RNAs [39,42] and with the observations that ORF57 homologs
SM and ICP27 can stabilize specific transcripts [63,64]. However,
these data are the first direct demonstration that KSHV ORF57
increases the half-lives of nuclear RNAs and that his function is
separable from its proposed roles in mRNA export, transcription,
and translation.
We observe only a slight increase in polymerase density on PAN
RNA genes driven from either the PAN or tetracycline-responsive
promoter (Figure 3). Therefore, we conclude ORF57 increases
PAN RNA levels primarily by a post-transcriptional mechanism.
We were surprised at the lack of increase in pol II density on the
constructs driven by the PAN promoter, which binds the viral
transactivator ORF50, an ORF57-interacting protein [38,39].
Assuming these proteins associate in our experimental system, the
interaction appears to have little effect on transcription initiation.
It should be noted that we used an antibody (8WG16) that
preferentially recognizes the initiating hypophosphorylated form of
pol II [65]. Thus, it remains possible that a hyperphosphorylated
elongating form of pol II increases on the PAN RNA gene in
response to ORF57. Taken with the observation that PAN RNA is
up-regulated by ORF57 from four different promoters (Figure 3A),
our data strongly support the conclusion that transcription
initiation is unaffected by ORF57.
ORF57 enhances the expression of viral mRNAs, the
noncoding nuclear PAN RNA, and heterologous reporter
mRNAs, so it appeared that its effects were not strongly
influenced by cis-acting sequences. On the contrary, our data
demonstrate that a specific cis-acting sequence, the ORE, can
enhance the effects of ORF57 on both PAN RNA and on a b-
globin reporter mRNA. Using a previously described set of
deletions [53], we show that ORF57 has reduced binding to
PAND1 RNA and that this correlates with loss of activity
(Figure 5, Figure 6). Moreover, we placed the ORE into an
intronless b-globin mRNA and found that it enhances ORF57-
responsiveness by ,5-fold, demonstrating that the ORE affects
mRNAs as well as the noncoding PAN RNA (Figure 8).
Tethering ORF57 to the ORE-lacking PAND1 transcripts in
cells is sufficient to complement the ORE deletion, so it seems
likely that ORF57 recruitment resides at the core of ORE activity
(Figure 7). The simplest interpretation of these results is that the
ORE is a high-affinity ORF57-binding site, and that RNA
binding by ORF57 is necessary for its stabilization activity.
Interestingly, intronless b-globin mRNA levels are enhanced by
ORF57 ,4-fold in the absence of the ORE. Perhaps ORF57 has
enough non-specific RNA-binding activity to account for its
general effects on reporter RNAs. Alternatively, this effect may be
linked to a separate ORF57 activity that functions independently
of RNA binding.
Mechanistically, our data support the model that ORF57 binds
to its RNA targets and inhibits the activity of nuclear RNA decay
enzymes, but we do not yet know the molecular details of ORF57-
mediated RNA stabilization. In one model, ORF57 binds RNA
making it inaccessible to RNA decay enzymes. Alternatively,
ORF57 could indirectly stabilize transcripts by promoting changes
in RNP composition or conformation. It remains formally possible
that ORF57 increases PAN RNA stability by retaining the
transcripts in the nucleus, thereby protecting them from
cytoplasmic decay enzymes. However, given the reported role of
ORF57 in mRNA export [40-42] and its ability to shuttle [66], we
think this last hypothesis is unlikely.
Our data are consistent with the model that ORF57 counteracts
a nuclear RNA quality control pathway that rapidly degrades
transcripts that derived from intronless genes [51–53,61,62]. It is
important to point out that this model does not depend on cells
specifically recognizing intronless RNAs. Rather, because of the
extensive coupling between the steps of cellular RNA biogenesis
including pre-mRNA splicing [16–27], we believe it more likely
that intronless RNAs are inefficiently processed. If RNA
surveillance and RNA maturation are in kinetic competition as
formally proposed by Doma and Parker [6], these inefficiently
processed intronless transcripts would be predicted to be subject to
degradation by RNA quality control pathways. Because the
majority of KSHV genes are intronless [14], we propose that
ORF57 functions to counteract this RNA decay pathway to
promote the robust expression of viral genes. ORF57 has been
reported to promote the export of intronless viral mRNAs [40–
43], so it is easy to imagine that ORF57 allows mRNAs to bypass
nuclear decay systems by enhancing the efficiency of their export.
However, in the case of PAN RNA, we can uncouple ORF57
mRNA export activities from its function in RNA stabilization.
Therefore, our data suggest a more active role for ORF57 in
protecting transcripts from degradation in the nucleus. Current
work focuses on further testing this model by identifying the
cellular decay machinery involved as well as the viral RNAs bound
and protected by ORF57.
Because PAN RNA accumulates to such high levels in KSHV
lytically reactivated cells [47,48,49], it likely performs an
important function for the virus. Therefore, studying the
biogenesis of this unusual transcript is essential to understanding
KSHV biology. In addition, PAN RNA provides a useful a tool to
separate ORF57 functions in RNA stability from its role in RNA
export. We used an unstable ENE-lacking PAN RNA for our
decay studies (Figure 2), but several observations suggest an
important role for ORF57 in PAN RNA biogenesis in infected
cells. First, steady-state levels of PAN RNA containing the ENE
are up-regulated in the presence of ORF57 (Figures 1 and 3).
Second, published reports have shown that ORF57-deleted
bacmids produce reduced levels of PAN RNA during lytic
infection [34,35]. Finally, we have observed that insertion of
multiple copies of the ENE leads to higher levels of PAN RNA
(unpublished observations) or bD1,2 mRNA [53] than insertion of
one ENE, suggesting that a single ENE does not completely block
RNA degradation. Thus, the proposed overlapping activities of the
ENE and ORF57 may both be essential to fully stabilize PAN
RNA during lytic replication. Perhaps more importantly, our
studies provide insights into the possible mechanism of ORF57
activity on the accumulation of intronless viral transcripts that lack
ENE-like elements. However, further experimentation is necessary
to test the role that ORF57 plays on PAN RNA stability in the
context of viral infection and on the stability of intronless viral
mRNAs.
A particularly interesting component of ORF57-mediated RNA
stabilization is the role of the poly(A) tail in regulation of transcript
stability. After transcription shut-off in the presence of ORF57, we
found that some transcripts become hyperadenylated, while others
are partially deadenylated (Figure 2, data not shown). Because
both the hypo- and hyperadenylated PAN transcripts are present 8
hrs subsequent to transcription shut-off, it seems that ORF57
stabilizes both forms. Indeed, when we over-expose our northern
blots, we observe transcripts resembling these hyper- and
hypoadenylated forms in the samples from cells lacking ORF57,
but at significantly reduced levels (data not shown). Several
different non-exclusive roles for the poly(A) tail in nuclear RNA
stability can be imagined that are consistent with our observations.
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aberrant transcript, presumably due to its lack of export. In
manner analogous to yeast and bacterial systems, hyperadenyla-
tion of the transcripts is linked to quality control [67,68].
Interestingly, the host-shutoff mechanism employed by KSHV
appears to involve destabilization of hyperadenylated cellular
mRNAs [69]. Moreover, recent work implicates mRNA export
factors as regulators of poly(A) length in cells and in polyadenyl-
ation assays performed in vitro [70–73]. In the second model,
ORF57 promotes polyadenylation, which then leads to greater
transcript stability. In a third model, ORF57 stabilizes nuclear
PAN RNA, and the hyperadenylation results from promiscuous
polyadenylation of the stabilized nuclear transcripts. Distinguish-
ing among these models will shed light into host-virus interactions
between KSHV ORF57, cellular poly(A) machinery, and cellular
RNA decay pathways.
Materials and Methods
Cell culture, cell lines, and transfection
HEK293, 293TOA, (Clontech) and 293A-TOA cells were
grown in Dulbecco’s Modified Eagle’s Medium (Sigma) supple-
mented with 10% fetal bovine serum (FBS), 1X penicillin-
streptomycin (Sigma), and 2 mM L-glutamate. TOA media
utilized tetracycline-free FBS (Clontech) and was supplemented
with 100 mg/mL G418 (Fisher Scientific). HH-B2 cells [74] were
cultured in RPMI-1640 media (Sigma) supplemented with 15%
FBS, 1X penicillin-streptomycin (Sigma), and 2 mM L-glutamate.
Transfections were performed using TransIT-293 reagent as per
the manufacturer’s protocol (Mirus). Most ORF57 titration
experiments were performed in 12-well tissue culture plates with
a total of 0.7–0.8 mg plasmid DNA. A typical transfection with
PAN-promoter constructs contained 0.15 mg of the PAN con-
struct, 0.15 mg of an ORF50 expression construct, which is
necessary for transcription from the PAN promoter, 0.1 mgo fa
control (mgU2-19/30) and 0.4 mg of Fl-ORF57 plus pcDNA3.
The control plasmid generates two products; one is a spliced non-
coding transcript and the other is an intron-derived scaRNA
important for methylation of U2 snRNA [75]. These transcripts
show little or no response to ORF57, under our typical
transfection conditions. However, they may slightly increase
(,2-fold) in the presence of ORF57 under the conditions used
in Figure 7 (see below). The result of this slight increase would
yield a relative underestimation of the effects of ORF57 in
Figure 7, so it does not alter our conclusions. When other
promoters were used, 0.3 mg of PAN RNA or b-globin expression
plasmids were transfected. Total RNA was harvested 18–24 hrs
post-transfection using TRI Reagent (Molecular Research Center).
The experiments shown in Figure 7 were slightly different. In this
case, we transfected 0.1 mg of the PAN RNA expression plasmids,
0.1 mg of the control plasmid and 0.4 and 0.8 mg of the Fl-ORF57,
MS2-NLS-Fl-ORF57, or MS2-NLS-Fl expression constructs.
Total RNA was harvested 44–50 hrs post-transfection. The
293A-TOA cell line was generated by transfecting 293A cells
(Invitrogen) with a tTA-expressing plasmid (Clontech). Stable
transformants were selected in 300 mg/ml G418 and cloned by
limiting dilution.
Decay assays
We have previously described the transcription pulse assay and
the quantitation of PAN RNA decay kinetics [51,52]. We
previously used HeLa Tet-off cells, but the expression of ORF57
in HeLa tet-off cells led to abrogation of the tetracycline-
responsiveness. The reason for this observation remains unknown.
In the current studies, we utilized 293TOA cells.
Plasmids
PAN-WT, PAND1, PAND2, PAND3, PAND4 and b-globin
reporters were described in [53], while PAN-D79, TRP-WT, and
TRP-D79 were described in [52]. PcFl-ORF57II (used to express
Fl-ORF57) was generated by PCR amplification ORF57 from
KSHV DNA using primers NC495 (59 ATTAGCGGATT-
CATGGTACAAGCAATGATAGAC 39) and NC496 (59 AA-
AAGGCTCGAGTTAAGAAAGTGGATAAAAGAATAAACC-
C3 9). Underlined sequence show relevant restriction sites. The
product was digested with BamHI and XhoI and inserted into
pcDNA-Flag (gift of Jens Lykke-Andersen, University of Colorado)
cut with the same. The sequence of all constructs using PCR-based
methods was verified. Consistent with previous reports [36,66],
this construct had a silent mutation (CAT to CAC) encoding for
the His at amino acid 261.
The CMVIE-WT (pcPAN) was made by PCR amplification of
PAN transcribed region and downstream sequence using primers
NC39 (59 ATTTCCAAGCTTACTGGGACTGCCCAGTCAC-
CTTGGCTGCCGCTTCACC 39) and NC42 (59 TAAAGC-
GGGCCCCCATCCCAATCGACGCAA 39). The product was
cut with ApaI, blunted, cut with HindIII and inserted into
pcDNA3 digested with BbsI, blunted, and then digested with
HindIII. The CMV-D1 derivative of this construct (pcPAND1) was
generated by PCR amplification with primers NC494 (59
CTCCGAAAGCTTACTGGGACTGCCATTCAATC 39) and
NC10 (59 GGGGGCCCGTCACATTTAGGGCAAAGTGG 39)
using PAND1 as a template. The product was digested with XbaI
and HindIII and inserted into pcPAN. The SV40 and EF1a-
driven constructs were also derivatives of pcPAN. In this case,
pcPAN was digested with NruI and HindIII to remove the CMVIE
promoter and SV40 or EF1a promoters were inserted using the
same restriction sites. Promoter sequences for SV40 and EF1a
were amplified using primers NC418 (59 GATCTCGC-
GACTCCCCAGGCAGGCAGAAGT 39) and NC419 (59 GAT-
CAAGCTTTGGATATACAAGCTCCCGGG 39), and NC416
(59 GATCTCGCGAGGCTCCGGTGCCCGTCAGTG 39) and
NC417 (59 GATCAAGCTTGAACGTTCACGGCGACTACT
39), respectively.
The NMS2-NLS-Fl expression vector (pcNMS2-NLS-Fl) was
constructed by amplifying the MS2 coat protein coding sequence
using primers NC448 (59 AGACCCAAGCTTGCCACCATG-
GCTTCT 39) and NC449 (59 GGATCCAAGCTTAGATCC-
ACCCTTGTCATCGTCGTCCTTGTAGTCTACCTTTCT-
CTTCTTTTTTGGTCCACCTCCACCTCCGTAGAT 39)
and pcNMS2 [59] as a template. The resulting fragment was
digested with HindIII and inserted into pcNMS2 digested with
HindIII. NMS2-NLS-Fl-ORF57 was generated by insertion of the
BamHI-XhoI fragment of pcFl-ORF57II into pcNMS2-NLS-Fl.
The CMV-D1-XMS2 construct (pcPAND1-XMS2) was generated
by amplifying six MS2-binding sites using primers NC584 (59
AAATGCTCTAGAAACTACCAAACTGGGTCTAG 39) and
NC134 (59 GACCCTAGATCTACTATAGAATAGGGCC-
CTCT 39), digestion of the resulting product with XbaI, and
insertion into pcPAND1 digested with XbaI.
ChIP assays
For ChIP assays, one 10 cm plate of HEK293 cells was used
(,10
7 cells) per sample. Twenty-four hours post-transfection
(plus/minus dox as indicated), methanol-free formaldehyde was
added to the media at final concentration of 0.75%. Plates were
incubated for 10 min and formaldehyde was quenched with
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1X phosphate buffered saline (Sigma), cells were harvested with a
rubber policeman and collected by centrifugation at 35006g for
3 min. Pellets were resuspended in 500 ml RIPA buffer (50 mM
Tris-HCl pH 8.0, 150 mM NaCl, 2 mM EDTA, 1% NP-40, 0.5%
sodium deoxycholate, 0.1% SDS) with 1X protease inhibitors
(cocktail V, Calbiochem), and 1 mM phenylmethanesulphonyl-
fluoride (PMSF), sonicated 6 times for 5 seconds using a Branson
Sonifier 450 with a 4.8 mm diameter micro tip producing an
average DNA size of ,250–1000 bp. The extracts were then
centrifuged at 8006g for 5 minutes at 4u and the supernatant was
pre-cleared for one hour with 20 ml of Protein-A agarose (Pierce).
After centrifugation to remove the beads, absorbance 260 was
determined. While this does not accurately reflect DNA
concentration due to the complexity of the extract, the value
can be used to equilibrate extract concentrations for immunopre-
cipitation (5% was placed at 220u as ‘‘input’’. Approximately 8 mg
of 8WG16 antibody (Abcam) was added to extract (except no
antibody control) and the mixture was nutated overnight at 4u.I n
addition, 20 ml of Protein-A agarose were blocked overnight at 4u
with 0.5 mg/ml sheared salmon sperm DNA and 0.1 mg/ml
bovine serum albumin (BSA) in RIPA. The next day, the beads
were added to the antibody-extract mixture and the nutated for
1.5 hr at 4u. The beads were then washed a total of six times by
nutating at room temperature for 3 minutes in 1 mL of the
following solutions: 1) RIPA, 2) low salt wash (0.1 SDS, 1%
TritonX100, 2 mM EDTA, 20 mM TRIS (pH 8), 150 mM
NaCl), 3) high salt wash (0.1 SDS, 1% TritonX100, 2 mM
EDTA, 20 mM TRIS (pH 8), 500 mM NaCl), 4) LiCl wash
(0.25 M LiCl, 1% NP40, 1% sodium deoxycholate, 1 mM EDTA,
10 mM Tris pH 8.0), 5) TE (10 mM Tris pH 8.0, 1 mM EDTA),
6) TE. After washing, the beads were nutated in 150 mL of elution
buffer (1% SDS, 100 mM NaHCO3, pH 9.0) for 15 min. The
elution step was repeated, the eluted fractions were combined,
60 ml 1M Tris-HCl (pH 6.8) was added to the eluted complexes,
proteinase K was added to 0.2 mg/ml and the samples were
incubated at 37u for 60 min. The crosslinks were subsequently
reversed at 65u for 5–18 hr. The samples were extracted with
phenol-chloroform isoamyl alcohol (25:24:1), ethanol precipitated
in the presence of 0.3M sodium acetate and 20 mg GlycoBlue
(Ambion). The pellets washed with 70% ethanol and resuspended
in 20 ml of water.
Real-time PCR and quantitation of ChIP assays
Input and pellet DNA was diluted 1:100 and 1:5, respectively
and 2 ml of this was used as template for a 20 ml real-time PCR
reaction containing iTAQ fast SYBR green supermix (Bio-Rad)
with a final concentration of 100 nM primers. Real-time PCR
parameters were 40 cycles of 95u for 3 sec and 60u for 30 sec using
a 7500 Fast Real-time PCR system (Applied Biosystems). Primers
used were: PAN 59, NC527 (59 CGCCGATTGTGGGTTGA 39)
and NC528 (59CGAAAGCCAGGATGGGTATATT 39); PAN
39, NC550 (59 TGTTTTAATGTGTATGTTGTGTTGGAAGT
39) and NC551 (59 TTCACCTACAAGAAAACATCGTTAGTC
39); GAPDH, NC533 (59 ATGGAAATCCCATCACCATCTT
39) and NC534 (59 CTAGTTGCCTCCCCAAAGCA 39).
Efficiency of the PAN 59, PAN 39 and GAPDH amplification
was determined to be 80%, 63%, and 72%, respectively [76].
Quantitation of the ChIP signals was performed as follows.
First, the relative quantities of Inputs and Pellets for each
experiment were determined based on their amplification
efficiency and the pellet/input ratio was determined. Each
experiment included a ‘‘no antibody’’ control and this pellet/
input value was subtracted from the other three samples.
Subsequently, the background corrected pellet/input PAN 59
and PAN 39 ratios were normalized to the corresponding GAPDH
ratios for the same experiment and the ‘‘no ORF57’’ values were
set to one. The p-values reported throughout the manuscript are
unpaired equal variance Student’s t-test values.
RNA immunoprecipitation assays, fluorescence in situ
hybridization, northern blotting
UV cross-linking and cell-mixing experiments were performed
as previously described [57], except poly(U) was omitted from the
protocol. Northern blotting was performed as in [53]. For in situ
hybridization analyses, PAN RNA was detected using a mix of




TCCAATA). In situ hybridization was performed as previously
described [53,77], except in the experiments shown in Figure S3,
direct labeling using FAM-conjugated oligonucleotides was
employed as an alternative to digoxygenin-tailing protocols.
Confocal and fluorescence microscopy was used in Figures 4
and S3, respectively.
Supporting Information
Table S1 Kinetic constants from PAN RNA decay experiments.
These constants were derived from nonlinear regressions of the
average values of each data point using the equation y=ae
2bx+
ce
2dx, where a + c=100, b,10, b.0, d.0. These data
correspond to the decay curves shown in Figure 2B. They differ
slightly from the values reported in Figure 2C and Figure S1.
These values were derived from a single regression of averaged
values for multiple experiments. The data displayed in Figure 2C
and Figure S1 were derived from independent regressions of each
data set. The latter calculations make it possible to determine
standard deviations for each parameter, while the former allow
display of a single regression in which each data point is shown
with standard deviation.
Found at: doi:10.1371/journal.ppat.1000799.s001 (0.04 MB
DOC)
Figure S1 Kinetic parameters of PAN RNA decay data. (A)
Percentage of PAN RNA transcripts in the ‘‘slow’’ decay pathway
is shown with standard deviation. These values are effectively the
inverse of those displayed in Figure 2C. (B) and (C) are the half-
lives determined of the slow and rapid RNA decay pathways,
respectively. As previously observed in experiments comparing
transcripts containing or lacking the ENE [51], the only parameter
consistently significantly affected by ORF57 is the fraction of PAN
RNA degrading in each population. Whether the lack of
significant differences in half-life determinations between the two
pools is due to experimental limitations or reflects a biological
phenomenon requires further exploration. Clearly, our data show
that the fraction of PAN RNA transcripts that are rapidly
degraded decreases when ORF57 is co-expressed.
Found at: doi:10.1371/journal.ppat.1000799.s002 (0.99 MB TIF)
Figure S2 RNA abundance in the absence of ORF57 from
multiple promoters. Quantitation of northern blot data showing
PAN RNA levels driven by each of the indicated promoters. All
values are relative to the PAN RNA promoter; error bars are
standard deviation (n=3). It should be noted that the PAN RNA
promoter construct is pBluescript-based while the others are
pcDNA3 derivatives, so it is possible that some of the basal
KSHV ORF57 Binds and Stabilizes PAN RNA
PLoS Pathogens | www.plospathogens.org 13 March 2010 | Volume 6 | Issue 3 | e1000799accumulation differences are due to this difference. All transcripts
utilize the PAN RNA polyadenylation signal.
Found at: doi:10.1371/journal.ppat.1000799.s003 (0.29 MB TIF)
Figure S3 TRP-D79 RNA remains nuclear in the presence of
ORF57. TRP-D79 was transfected into 293A-TOA cells and the
transfected cells were used for in situ hybridization with PAN
RNA probes (middle). PAN RNA signal is shown in the presence
and absence (vector) of ORF57 as indicated. Nuclei are stained
with DAPI (left) and merged images are shown (right panels).
Found at: doi:10.1371/journal.ppat.1000799.s004 (6.40 MB TIF)
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